Extended Data Fig. 3: Supplementary data for clinical outcomes and the fungal intestinal mycobiota, related to Fig. 5.

(a) Overall survival and (b) transplant-related mortality in relation to a relative abundance of C. parapsilosis complex ≥ 82% within the pre-engraftment period (days 0 to the first day of an absolute neutrophil count > 500/mm3). (a) Kaplan–Meier curves tested by two-sided log-rank test. (b) Cumulative incidence curves with relapse and progression of primary disease as competing interest. Differences tested by two-sided Gray’s test. (c) Overall survival and (d) transplant-related mortality in relation to domination by C. albicans within the pre-engraftment period (days 0 to the first day of an absolute neutrophil count > 500/mm3). (c) Kaplan–Meier curves tested by two-sided log-rank test. (d) Cumulative incidence curves with relapse and progression of primary disease as competing interest. Differences tested by two-sided Gray’s test. (a–d) Numbers below the graphs correspond to the number of patients (still) at risk at the specific time point.